Matrix Metalloproteinases and Platelet Function

Versteeg, 2013, New fundamentals in hemostasis, Physiol Rev, 93, 327, 10.1152/physrev.00016.2011 Italiano, 2016, Megakaryocyte development and platelet production, 39 Harker, 1996, Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates, Blood, 87, 1833, 10.1182/blood.V87.5.1833.1833 Semple, 2011, Platelets and the immune continuum, Nat Rev Immunol, 11, 264, 10.1038/nri2956 Nurden, 2011, Platelets, inflammation and tissue regeneration, Thromb Haemost, 105, S13, 10.1160/THS10-11-0720 Rowley, 2011, Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes, Blood, 118, e101, 10.1182/blood-2011-03-339705 Berndt, 2014, Primary haemostasis: newer insights, Haemophilia, 20, 15, 10.1111/hae.12427 Andrews, 2008, Platelet adhesion: a game of catch and release, J Clin Invest, 118, 3009 Stalker, 2012, Platelet signaling, Handb Exp Pharmacol, 210, 59, 10.1007/978-3-642-29423-5_3 Vezza, 1993, Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C, Blood, 82, 2704, 10.1182/blood.V82.9.2704.2704 Gresele, 2008, Potentiation and priming of platelet activation: a potential target for antiplatelet therapy, Trends Pharmacol Sci, 29, 352, 10.1016/j.tips.2008.05.002 Ciferri, 2000, Platelets release their lysosomal content in vivo in humans upon activation, Thromb Haemost, 83, 157, 10.1055/s-0037-1613772 Diamond, 2013, Systems biology of coagulation, J Thromb Haemost, 11, 224, 10.1111/jth.12220 Panes, 2007, Human platelets synthesize and express functional tissue factor, Blood, 109, 5242, 10.1182/blood-2006-06-030619 Camera, 2015, The role of tissue factor in atherothrombosis and coronary artery disease: insights into platelet tissue factor, Semin Thromb Hemost, 41, 737, 10.1055/s-0035-1564041 de Witt, 2014, Insights into platelet-based control of coagulation, Thromb Res, 133, S139, 10.1016/S0049-3848(14)50024-2 Santos-Martínez, 2008, Role of metalloproteinases in platelet function, Thromb Res, 121, 535, 10.1016/j.thromres.2007.06.002 Chesney, 1974, Human platelet collagenase, J Clin Invest, 53, 1647, 10.1172/JCI107715 Galt, 2002, Outside-in signals delivered by matrix metalloproteinase-1 regulate platelet function, Circ Res, 90, 1093, 10.1161/01.RES.0000019241.12929.EB Trivedi, 2009, Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site, Cell, 137, 332, 10.1016/j.cell.2009.02.018 Cecchetti, 2011, Megakaryocytes differentially sort mRNAs for matrix metalloproteinases and their inhibitors into platelets: a mechanism for regulating synthetic events, Blood, 118, 1903, 10.1182/blood-2010-12-324517 Galt, 2001, Differential regulation of matrix metalloproteinase-9 by monocytes adherent to collagen and platelets, Circ Res, 89, 509, 10.1161/hh1801.096339 Kälvegren, 2011, Release of matrix metalloproteinases-1 and -2, but not -9, from activated platelets measured by enzyme-linked immunosorbent assay, Platelets, 22, 572, 10.3109/09537104.2011.583300 Falcinelli, 2011, MMP-9 in platelets: maybe maybe not, Blood, 118, 6471, 10.1182/blood-2011-10-379222 Fernandez-Patron, 1999, Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2, Thromb Haemost, 82, 1730, 10.1055/s-0037-1614906 Sheu, 2004, Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies, Br J Pharmacol, 143, 193, 10.1038/sj.bjp.0705917 Wrzyszcz, 2012, On the origin of matrix metalloproteinase-2 and -9 in blood platelets, Platelets, 23, 467, 10.3109/09537104.2012.682103 Mastenbroek, 2015, Platelet-associated matrix metalloproteinases regulate thrombus formation and exert local collagenolytic activity, Arterioscler Thromb Vasc Biol, 35, 2554, 10.1161/ATVBAHA.115.306153 Kim, 2003, Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor, Eur J Cancer, 39, 184, 10.1016/S0959-8049(02)00596-8 Malik, 2005, Matrix metalloproteinases in isolated hypercholesterolemia, Int Angiol, 24, 300 Visse, 2003, Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry, Circ Res, 92, 827, 10.1161/01.RES.0000070112.80711.3D Stetler Stevenson, 2008, Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities, Sci Signal, 1, re6, 10.1126/scisignal.127re6 Zhao, 2013, Platelet-derived growth factor-D promotes fibrogenesis of cardiac fibroblasts, Am J Physiol Heart Circ Physiol, 304, H1719, 10.1152/ajpheart.00130.2013 Eichler, 2002, Modulation of matrix metalloproteinase and TIMP-1 expression by cytokines in human RPE cells, Invest Ophthalmol Vis Sci, 43, 2767 Murate, 1997, The production of tissue inhibitors of metalloproteinases (TIMPs) in megakaryopoiesis: possible role of platelet- and megakaryocyte-derived TIMPs in bone marrow fibrosis, Br J Haematol, 99, 181, 10.1046/j.1365-2141.1997.3293146.x Gomis-Rüth, 1997, Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1, Nature, 389, 77, 10.1038/37995 Overall, 2000, Domain interactions in the gelatinase A.TIMP-2.MT1-MMP activation complex. The ectodomain of the 44-kDa form of membrane type-1 matrix metalloproteinase does not modulate gelatinase A activation, J Biol Chem, 275, 39497, 10.1074/jbc.M005932200 Kazes, 2000, Platelet release of trimolecular complex components MT1-MMP/TIMP2/MMP2: involvement in MMP2 activation and platelet aggregation, Blood, 96, 3064, 10.1182/blood.V96.9.3064 Chang, 2001, The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis, Trends Cell Biol, 11, S37, 10.1016/S0962-8924(01)02122-5 Brew, 1803, The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity, Biochim Biophys Acta, 2010, 55 Rowley, 2012, Platelet mRNA: the meaning behind the message, Curr Opin Hematol, 19, 385, 10.1097/MOH.0b013e328357010e Weis, 1833, Protein targeting to subcellular organelles via MRNA localization, Biochim Biophys Acta, 2013, 260 Martin, 2009, mRNA localization: gene expression in the spatial dimension, Cell, 136, 719, 10.1016/j.cell.2009.01.044 Fusco, 2003, Single mRNA molecules demonstrate probabilistic movement in living mammalian cells, Curr Biol, 13, 161, 10.1016/S0960-9822(02)01436-7 Lood, 2010, Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease, Blood, 116, 1951, 10.1182/blood-2010-03-274605 Raghavachari, 2007, Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease, Circulation, 115, 1551, 10.1161/CIRCULATIONAHA.106.658641 Healy, 2006, Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events, Circulation, 113, 2278, 10.1161/CIRCULATIONAHA.105.607333 Villeneuve, 2009, Tissue inhibitors of matrix metalloproteinases in platelets and megakaryocytes: a novel organization for these secreted proteins, Exp Hematol, 37, 849, 10.1016/j.exphem.2009.03.009 Sawicki, 1998, Localization and translocation of MMP-2 during aggregation of human platelets, Thromb Haemost, 80, 836, 10.1055/s-0037-1615367 Radomski, 2002, Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets, Br J Pharmacol, 137, 1330, 10.1038/sj.bjp.0704936 Sawicki, 1997, Release of gelatinase A during platelet activation mediates aggregation, Nature, 386, 616, 10.1038/386616a0 Falcinelli, 2005, Intraplatelet signaling mechanisms of the priming effect of matrix metalloproteinase-2 on platelet aggregation, J Thromb Haemost, 3, 2526, 10.1111/j.1538-7836.2005.01614.x Cognasse, 2014, Streptococcus sanguinis-induced cytokine and matrix metalloproteinase-1 release from platelets, BMC Immunol, 15, 15, 10.1186/1471-2172-15-15 Bennet, 2016, αIIbβ3 (GPIIb/IIIa) structure and function, 99 Stricker, 2001, Structural analysis of the alpha(2) integrin I domain/procollagenase-1 (matrix metalloproteinase-1) interaction, J Biol Chem, 276, 29375, 10.1074/jbc.M102217200 Brooks, 1996, Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3, Cell, 85, 683, 10.1016/S0092-8674(00)81235-0 Radomski, 2001, Pharmacological characteristics of solid-phase von Willebrand factor in human platelets, Br J Pharmacol, 134, 1013, 10.1038/sj.bjp.0704345 Ossovskaya, 2004, Protease-activated receptors: contribution to physiology and disease, Physiol Rev, 84, 579, 10.1152/physrev.00028.2003 Jaffré, 2012, β-adrenergic receptor stimulation transactivates protease-activated receptor 1 via matrix metalloproteinase 13 in cardiac cells, Circulation, 125, 2993, 10.1161/CIRCULATIONAHA.111.066787 Sebastiano, 2016, MMP-2 mediates PAR1 biased signaling in human platelets: a novel mechanism regulating platelet activation, Blood Lane, 2000, Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases, Blood, 96, 4152, 10.1182/blood.V96.13.4152 Kato, 2005, Levels of matrix metalloproteinase-1 in patients with and without coronary artery disease and relation to complex and noncomplex coronary plaques, Am J Cardiol, 95, 90, 10.1016/j.amjcard.2004.08.066 Suzuki, 2008, Elevation of matrix metalloproteinases and interleukin-6 in the culprit coronary artery of myocardial infarction, Eur J Clin Invest, 38, 166, 10.1111/j.1365-2362.2007.01919.x Falcinelli, 2007, Platelets release active matrix metalloproteinase-2 in vivo in humans at a site of vascular injury: lack of inhibition by aspirin, Br J Haematol, 138, 221, 10.1111/j.1365-2141.2007.06632.x Tomaiuolo, 2014, A systems approach to hemostasis: 2. Computational analysis of molecular transport in the thrombus microenvironment, Blood, 124, 1816, 10.1182/blood-2014-01-550343 Schulz, 2007, Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches, Annu Rev Pharmacol Toxicol, 47, 211, 10.1146/annurev.pharmtox.47.120505.105230 Soslau, 2014, Intracellular matrix metalloproteinase-2 (MMP-2) regulates human platelet activation via hydrolysis of talin, Thromb Haemost, 111, 140, 10.1160/TH13-03-0248 Reinboldt, 2009, Preliminary evidence for a matrix metalloproteinase-2 (MMP-2)-dependent shedding of soluble CD40 ligand (sCD40L) from activated platelets, Platelets, 20, 441, 10.1080/09537100903096684 Choi, 2010, CD40 ligand shedding is regulated by interaction between matrix metalloproteinase-2 and platelet integrin alpha(IIb)beta(3), J Thromb Haemost, 8, 1364, 10.1111/j.1538-7836.2010.03837.x Martinez-Cuesta, 2001, Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: interactions with nitric oxide, Med Sci Monit, 7, 646 Guglielmini, 2016, Matrix metalloproteinase-2 enhances platelet deposition on collagen under flow conditions, Thromb Haemost, 115, 333, 10.1160/TH15-04-0300 Gresele, 2011, Platelets release matrix metalloproteinase-2 in the coronary circulation of patients with acute coronary syndromes: possible role in sustained platelet activation, Eur Heart J, 32, 316, 10.1093/eurheartj/ehq390 Jurasz, 2001, Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide, Cancer Res, 61, 376 Lee, 2006, Inhibitory mechanisms of activated matrix metalloproteinase-9 on platelet activation, Eur J Pharmacol, 537, 52, 10.1016/j.ejphar.2006.03.031 Nakamura, 1998, Modulation of plasma metalloproteinase-9 concentrations and peripheral blood monocyte mRNA levels in patients with septic shock: effect of fiber-immobilized polymyxin B treatment, Am J Med Sci, 316, 355 Hotary, 2000, Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3, J Cell Biol, 149, 1309, 10.1083/jcb.149.6.1309 Koshikawa, 2000, Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5, J Cell Biol, 148, 615, 10.1083/jcb.148.3.615 Howes, 2015, Modified platelet deposition on matrix metalloproteinase 13 digested collagen I, J Thromb Haemost, 13, 2253, 10.1111/jth.13166 Villeneuve, 2010, Tissue inhibitor of matrix metalloproteinase-1 reduces phosphatidylserine exposure on activated and aged platelets, Br J Haematol, 149, 302, 10.1111/j.1365-2141.2009.08047.x Kasper, 2007, Matrix metalloprotease activity is an essential link between mechanical stimulus and mesenchymal stem cell behavior, Stem Cells, 25, 1985, 10.1634/stemcells.2006-0676 Hire, 2014, Variance of matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) concentrations in activated, concentrated platelets from healthy male donors, J Orthop Surg Res, 9, 29, 10.1186/1749-799X-9-29 Chung, 2004, Platelet-leukocyte aggregation induced by PAR agonists: regulation by nitric oxide and matrix metalloproteinases, Br J Pharmacol, 143, 845, 10.1038/sj.bjp.0705997 May, 2002, Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells, Circulation, 106, 2111, 10.1161/01.CIR.0000033597.45947.0F Belloc, 1995, The effect of platelets on invasiveness and protease production of human mammary tumor cells, Int J Cancer, 60, 413, 10.1002/ijc.2910600324 Alonso-Escolano, 2004, Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins, Br J Pharmacol, 141, 241, 10.1038/sj.bjp.0705606 Janowska-Wieczorek, 2005, Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer, Int J Cancer, 113, 752, 10.1002/ijc.20657 Dashevsky, 2009, Platelet-derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP-2 production, Int J Cancer, 124, 1773, 10.1002/ijc.24016 Shin, 2014, The effects of platelet-rich clot releasate on the expression of MMP-1 and type I collagen in human adult dermal fibroblasts: PRP is a stronger MMP-1 stimulator, Mol Biol Rep, 41, 3, 10.1007/s11033-013-2718-9 Petito, 2014, Platelets participate in joint inflammation osteoarthritis: prevention by hyaluronic acid, Thromb Res, 134, S79 Maione, 1990, Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides, Science, 247, 77, 10.1126/science.1688470 Jin, 2006, Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4(+) hemangiocytes, Nat Med, 12, 557, 10.1038/nm1400 Kopp, 2006, Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization, J Clin Invest, 116, 3277, 10.1172/JCI29314 Momi, 2009, Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo, J Exp Med, 206, 2365, 10.1084/jem.20090687 Pyo, 2000, Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms, J Clin Invest, 105, 1641, 10.1172/JCI8931 Longo, 2002, Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms, J Clin Invest, 110, 625, 10.1172/JCI0215334 Liu, 2012, Clopidogrel, a platelet P2Y12 receptor inhibitor, reduces vascular inflammation and angiotensin II induced-abdominal aortic aneurysm progression, PLoS One, 7, 10.1371/journal.pone.0051707 Owens, 2015, Platelet inhibitors reduce rupture in a mouse model of established abdominal aortic aneurysm, Arterioscler Thromb Vasc Biol, 35, 2032, 10.1161/ATVBAHA.115.305537 Rahman, 2009, Platelet-derived CD40L (CD154) mediates neutrophil upregulation of Mac-1 and recruitment in septic lung injury, Ann Surg, 250, 783, 10.1097/SLA.0b013e3181bd95b7 Rahman, 2013, Platelet shedding of CD40L is regulated by matrix metalloproteinase-9 in abdominal sepsis, J Thromb Haemost, 11, 1385, 10.1111/jth.12273 Kerr, 2013, Platelets govern pre-metastatic tumor communication to bone, Oncogene, 32, 4319, 10.1038/onc.2012.447 Fanjul-Fernández, 2013, Matrix metalloproteinase Mmp-1a is dispensable for normal growth and fertility in mice and promotes lung cancer progression by modulating inflammatory responses, J Biol Chem, 288, 14647, 10.1074/jbc.M112.439893 Tressel, 2011, A matrix metalloprotease-PAR1 system regulates vascular integrity, systemic inflammation and death in sepsis, EMBO Mol Med, 3, 370, 10.1002/emmm.201100145 Newby, 2015, Metalloproteinases promote plaque rupture and myocardial infarction: A persuasive concept waiting for clinical translation, Matrix Biol., 44–46, 157, 10.1016/j.matbio.2015.01.015 Galis, 2002, Matrix metalloproteinases in vascular remodeling and atherogenesis the good, the bad, and the ugly, Circ Res, 90, 251, 10.1161/res.90.3.251 Kai, 1998, Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes, J Am Coll Cardiol, 32, 368, 10.1016/S0735-1097(98)00250-2 Inoue, 2003, Circulating matrix metalloproteinase-1 and -3 in patients with an acute coronary syndrome, Am J Cardiol, 92, 1461, 10.1016/j.amjcard.2003.08.061 Soejima, 2003, Increased serum matrix metalloproteinase-1 concentration predicts advanced left ventricular remodeling in patients with acute myocardial infarction, Circ J, 67, 301, 10.1253/circj.67.301 Cavusoglu, 2015, Relation of baseline plasma MMP-1 levels to long-term all-cause mortality in patients with known or suspected coronary artery disease referred for coronary angiography, Atherosclerosis, 239, 268, 10.1016/j.atherosclerosis.2015.01.003 Choudhary, 2006, Quantitation and localization of matrix metalloproteinases and their inhibitors in human carotid endarterectomy tissues, Arterioscler Thromb Vasc Biol, 26, 2351, 10.1161/01.ATV.0000239461.87113.0b Back, 2010, Matrix metalloproteinases in atherothrombosis, Prog Cardiovasc Dis, 52, 410, 10.1016/j.pcad.2009.12.002 Lenti, 2014, Matrix metalloproteinase-2 of human carotid atherosclerotic plaques promotes platelet activation. Correlation with ischaemic events, Thromb Haemost, 111, 1089, 10.1160/TH13-07-0588 Toschi, 1997, Tissue factor modulates the thrombogenicity of human atherosclerotic plaques, Circulation, 95, 594, 10.1161/01.CIR.95.3.594 Penz, 2007, Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques, Thromb Haemost, 97, 435, 10.1160/TH06-07-0415 Reininger, 2010, A 2-step mechanism of arterial thrombus formation induced by human atherosclerotic plaques, J Am Coll Cardiol, 55, 1147, 10.1016/j.jacc.2009.11.051 Nikkari, 1995, Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis, Circulation, 92, 1393, 10.1161/01.CIR.92.6.1393 Sukhova, 1999, Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques, Circulation, 99, 2503, 10.1161/01.CIR.99.19.2503 Kurzepa, 2014, The significance of matrix metalloproteinase (MMP)-2 and MMP-9 in the ischemic stroke, Int J Neurosci, 124, 707, 10.3109/00207454.2013.872102 Lenglet, 2015, Role of matrix metalloproteinases in animal models of ischemic stroke, Curr Vasc Pharmacol, 13, 161, 10.2174/15701611113116660161 Busti, 2010, Matrix metalloproteinases and peripheral arterial disease, Intern Emerg Med, 5, 13, 10.1007/s11739-009-0283-y Tayebjee, 2005, Abnormal circulating levels of metalloprotease 9 and its tissue inhibitor 1 in angiographically proven peripheral arterial disease: relationship to disease severity, J Intern Med, 257, 110, 10.1111/j.1365-2796.2004.01431.x Signorelli, 2012, Patients with unrecognized peripheral arterial disease (PAD) assessed by ankle-brachial index (ABI) present a defined profile of proinflammatory markers compared to healthy subjects, Cytokine, 59, 294, 10.1016/j.cyto.2012.04.038 Burdess, 2010, Perioperative platelet and monocyte activation in patients with critical limb ischemia, J Vasc Surg, 52, 697, 10.1016/j.jvs.2010.04.024 Gresele, 1997, Platelet activation markers in patients with peripheral arterial disease—a prospective comparison of different platelet function tests, Thromb Haemost, 78, 1434, 10.1055/s-0038-1665429 Danese, 2003, Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients, Gastroenterology, 124, 1249, 10.1016/S0016-5085(03)00289-0 Gotoh, 2004, Increased CD40 expression on articular chondrocytes from patients with rheumatoid arthritis: contribution to production of cytokines and matrix metalloproteinases, J Rheumatol, 31, 1506 Büchner, 2003, CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40-CD40L signalling in atherosclerosis, J Pathol, 201, 288, 10.1002/path.1425 Henn, 1998, CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells, Nature, 391, 591, 10.1038/35393 Rigothier, 2016, CD154 induces matrix metalloproteinase-9 secretion in human podocytes, J Cell Biochem, 117, 2737, 10.1002/jcb.25571 Morrell, 2014, Emerging roles for platelets as immune and inflammatory cells, Blood, 123, 2759, 10.1182/blood-2013-11-462432 Petito, 2014, Platelets participate in synovial inflammation in rheumatoid arthritis by increasing MMP-2 formation, Thromb Res, 134, S80 Catricala, 2012, Alzheimer disease and platelets: how's that relevant, Immun Ageing, 9, 20, 10.1186/1742-4933-9-20 Lim, 2011, Investigation of matrix metalloproteinases, MMP-2 and MMP-9, in plasma reveals a decrease of MMP-2 in Alzheimer's disease, J Alzheimers Dis, 26, 779, 10.3233/JAD-2011-101974 Hochstrasser, 2012, Matrix metalloproteinase-2 and epidermal growth factor are decreased in platelets of Alzheimer patients, Curr Alzheimer Res, 9, 982, 10.2174/156720512803251156 Li, 2014, Presence of intratumoral platelets is associated with tumor vessel structure and metastasis, BMC Cancer, 14, 167, 10.1186/1471-2407-14-167 Bastida, 1986, Morphometric evaluation of thrombogenesis by microvesicles from human tumor cell lines with thrombin-dependent (U87MG) and adenosine diphosphate-dependent (SKNMC) platelet-activating mechanisms, J Lab Clin Med, 108, 622 Heinmöller, 1996, Studies on tumor-cell-induced platelet aggregation in human lung cancer cell lines, J Cancer Res Clin Oncol, 122, 735, 10.1007/BF01209121 Boukerche, 1994, Human melanoma cell lines differ in their capacity to release ADP and aggregate platelets, Br J Haematol, 87, 763, 10.1111/j.1365-2141.1994.tb06736.x Jurasz, 2003, Matrix metalloproteinase-2 contributes to increased platelet reactivity in patients with metastatic prostate cancer: a preliminary study, Thromb Res, 112, 59, 10.1016/j.thromres.2003.10.012 Foley, 2014, Matrix metalloprotease 1a deficiency suppresses tumor growth and angiogenesis, Oncogene, 33, 2264, 10.1038/onc.2013.157 Helley, 2009, Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapy, Eur Urol, 56, 479, 10.1016/j.eururo.2008.06.038 Momi, 2016, Phylogeny of blood platelets, 11